Dr. Shimada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-8000
Education & Training
- Yokohama City University School of MedicineClass of 1973
Certifications & Licensure
- CA State Medical License 2006 - 2025
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- Favorable outcomes of de novo advanced phases of pediatric chronic myeloid leukemia in the tyrosine kinase inhibitor era.Toshihide Yoshikawa, Hisashi Ishida, Akihiro Watanabe, Yuki Yuza, Haruko Shima
International Journal of Hematology. 2025-03-15 - Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR).Jason A Jarzembowski, Fleur Webster, Klaus Beiske, Susan L Cohn, Ronald R de Krijger
Histopathology. 2025-02-24 - Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.Haruko Shima, Chikako Tono, Akihiko Tanizawa, Masaki Ito, Akihiro Watanabe
Leukemia. 2025-02-01
Press Mentions
- Preclinical Assessment of the Efficacy and Specificity of GD2-B7H3 SynNotch CAR-T in Metastatic NeuroblastomaJanuary 21st, 2021
- In Japan, Driving Skill Training for Older Drivers Enhances SafetyNovember 9th, 2020
- HTLV-I-associated Myelopathy: Acute Progression and Atypical MR FindingsNovember 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: